Translational medicine: ways of development in modern conditions, problems and prospects
Abstract
Summary. Introduction The article is devoted to the achievements and prospects of the development of translational medicine at the international level, the state of development, problems and prospects in Ukraine, proposals for improving the system of innovations in health care in modern conditions of martial law. The purpose is to study the development of translational medicine and the prospects for implementing its principles in Ukraine. Materials and methods. To perform the task, an analytical review of publications in the electronic databases of medical and biological publications PubMed Medline of the US National Library of Medicine (NLM), Cochrane Database of Systematic Reviews was conducted. The results. The result of a systematic literature review of the state of translational medicine in Ukraine, which was carried out, is the conviction that the need to create new services and programs that ensure close cooperation between state, commercial and non-commercial organizations of our country, greater accessibility and transparency of new data for all is ripe. Researchers working in the field of broadcasts of inventions. The creation and development of databases with various information on a large number of patients opens wide opportunities for improving the quality of preclinical and clinical trials, and at the same time requires increasing their availability for researchers around the world. It is necessary to increase the use of the potential of social media and/or messengers for the introduction of modern achievements of translational medicine into the clinical practice of our country, the medical community should receive educational programs, recommendations and support infrastructure in social networks. Conclusions. In order to form an effective scientific and educational environment, it is necessary to create a national Institute of Pharmacy and Translational Medicine. It is necessary to create and implement in the educational pharmaceutical space of Ukraine an innovative educational program aimed at training specialists and research personnel of the new generation to work in various branches of the biopharmaceutical industry. It is expedient to create biological models of the use of drugs that allow testing of dose-response effects and to build pharmacokinetic models for specific environmental conditions, which will increase the predictive power of test results during its transition to the stage of clinical trials.
Downloads
References
CDBI/INF (2000) [cdbi/plénier/docs publics/inf/travaux préparatoires Conv. (2000.1)]. Available from: https://www.coe.int/t/dg3/healthbioethic/texts_and_documents/CDBI-INF%282000%291PrepConv.pdf
Geraghty J. Adenomatous polyposis coli and translational medicine. Lancet. 1996 Aug 17;348(9025):422. DOI: 10.1016/S0140-6736(05)64535-7.
Kowalski TW, Sanseverino MT, Schuler-Faccini L, Vianna FS. Thalidomide embryopathy: Follow-up of cases born between 1959 and 2010. Birth Defects Res A Clin Mol Teratol. 2015. Sep; 103(9):794–803. DOI: 10.1002/bdra.23376.
Yao Q, Lyu PH, Ma FC, Yao L, Zhang SJ. Clobal infometric perspective studies of translational medicine. BMC Med. Inform. Decis. Mak. 2013;13:77. DOI: 10.1186/1472-6947-13-77.
Christopher P. Austin. Opportunities and challenges in translational science. National Center for Advancing Translational Sciences. Bethesda, MD, USA: NCATS; 12 April 2021. Clin. Transl. Sci. 2021;14:1629–1647. Available from: https://ncats. nih.gov/translation/spectrum.
Lіnchevs'kij OV, CHernenko VM, P’yatnic'kij YuS, Bulah ІЄ. SHlyahi reformuvannya sistemi vishchoї medichnoї osvіti v Ukraїnі v suchasnih umovah.. Aktual'nі pitannya yakostі medichnoї osvіti : materіali XIV Vseukr. nauk.- prakt. konf. z mіzhnar. uchastyu (z distancіjnim pіd’єdnannyam VM(F)NZ Ukraїni za dopomogoyu vіdeokonferenc-zv’yazku) (Ternopіl', 18–19 trav. 2017 r.). Ternopіl', 2017. T. 1. S. 3-5. [Ukrainian].
Krasnov VV, Sіchkorіz OЄ, SHCHerbіns'ka OS. Zmіni v sistemі pіdgotovki medichnih kadrіv v umovah reformuvannya sferi ohoroni zdorov’ya. Aktual'nі pitannya yakostі medichnoї osvіti : materіali XIV Vseukr. nauk.-prakt. konf. z mіzhnar. uchastyu (z distancіjnim pіd’єdnannyam VM(F)NZ Ukraїni za dopomogoyu vіdeokonferenc-zv’yazku) (Ternopіl', 18–19 trav. 2017 r.). Ternopіl', 2017. T. 1. s. 121-122. [Ukrainian].
Supporting the Transformative Impact of Research Infrastructures on European Research. 2020. Available from: https://ec.europa.eu/info/sites/info/files/research_and_innovation/strategy_on_research_and_innovation/documents/ec_rtd_transformative-impact-ris-on-euro-research.pdf
Chan T, Trueger NS, Roland D, Thoma B. Evidence-based medicine in the era of social media: scholarly engagement through participation and online interaction. Can J. Emerg. Med. 2018;20:3–8. DOI: 10.1017/cem.2016.407.
Fritsche E, Crofton KM, Hernandez AF, Hougaard Bennekou S, Leist M, Bal-Price A, et al. OECD/EFSA workshop on developmental neurotoxicity (DNT): The use of non-animal test methods for regulatory purposes. ALTEX. 2017;34(2):311-315. DOI: 10.14573/altex.1701171.
Mehić B. Translational research in medicine. Bosn. J. of Basic Med. Sci. 2011. May 20 [cited 2022Sep.12];11(2):73. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/2583.
Liao W, Du C, Wang J. The cGAS-STING Pathway in Hematopoiesis and Its Physiopathological Significance. Front Immunol. 2020 Nov 30;11:573915. DOI: 10.3389/fimmu.2020.573915.
Hajishengallis G, Chavakis T. Inflammatory memory and comorbidities. Clin Transl Med. 2022 Jul;12(7):e984. DOI: 10.1002/ctm2.984.
Rovida C, Asakura S, Daneshian M, Hofman-Huether H, Leist M, Meunier L, et al. Toxity Testing in the 21st Centure beyond environmental chemicals. ALTEX. 2015;32 (3):171–81. DOI: 10.14573/altex.1506201.
Krewski D, Acosta D Jr., Andersen M, Anderson H, Bailar JC, Boekelheide K, et al. Toxity Testing in the 21st century: A Vision and A Strategy. J. Toxico. l Envirom. Health B Crit. Rev. 2010 Feb; 13 (0): 51–138. DOI: 10.1080/10937404.2010.483176.
Westfall JM, Mold J, Fagnan L. Practice-based research --"Blue Highways" on the NIH roadmap. JAMA. 2007 Jan 24;297(4):403-6. DOI: 10.1001/jama.297.4.403.
National Center for Advancing Translational Sciences. Bethesda, MD, USA: NCATS; [updated 2016. Dec. 22; cited 2016 Dec.]. Translational Science Spectrum; [about 2 screens]. Available from: https://ncats.nih.gov/translation/spectrum.
Trochim W, Kane C, Graham MJ, Pincus HA. Evaluating translational research: a process marker model. Clin. Transl. Sci. 2011 Jun;4(3):153-62. DOI: 10.1111/j.1752-8062.2011.00291.x.
NCATS Programs & Initiatives. National Center for Advancing Translational Sciences. 2015-03-16. Retrieved 2021-09-28.
Baltimore D, Berg P, Botchan M, Carroll D, Charo RA, Church G, et al. A prudent path forward for genomic engineering and germline gene modification. Science. 2015. Apr. 3;348(6230):36–3. DOI: 10.1126/science.aab1028.
Knapton S. British scientists granted permission to genetically modify human embryos. The Daily Telegraph. 2016. Feb. 1.
Bіblіografіchnij pokazhchik naukovih prac' spіvrobіtnikіv ІEPOR іm. R.Є. Kavec'kogo NAN Ukraїni. 1960-2010 rr. Vіdp. red. V.F. CHekhun; Ukladachі: P.M. SHkatula, N.M. SHarc. K.: DІA, 2010. 32 s. [Ukrainian].
Mihajlenko V.M., D'omіna E.A., Glavіn O.A., Muzal'ov І.І. Sposіb ocіnki nebezpeki poєdnanoї dії ekzogennih oksidіv azotu ta malih doz іonіzuyuchoї radіacії na organіzm lyudini: Іnform. list. K., 2013. 5 s. [Ukrainian].
D'omіna EA, Ryabchenko NM, Druzhina MO, CHekhun VF. Citogenetichnij sposіb (G2-assay) viznachennya іndivіdual'noї radіochutlivostі lyudini z metoyu pervinnoї profіlaktiki radіogennogo raku: Metod. rekomendacії. K., 2007. 28 s. [Ukrainian].
Potebnya GP, Dіdenko GV, Lіsovenko GS, SHpak ЄG, Kuz'menko OP, Bojko ІІ. Dіagnostichna test-sistema dlya monіtorіngu onkologіchnih zahvoryuvan': Іnformacіjnij list. K., 2012. № 423. 4 s. [Ukrainian].
Potebnya GP, Bombіn AV, Lіsovenko GS, Bojko ІІ. Vikoristannya protipuhlinnoї autovakcini v kompleksnomu lіkuvannі hvorih zі zloyakіsnimi puhlinami golovnogo mozku: Metod. Rekomendacії. K., 2011. 19 s. [Ukrainian].
Onoprієnko VІ. Nacіonal'nij tekhnіchnij unіversitet Ukraїni (KPІ). Enciklopedіya іstorії Ukraїni : u 10 t. / redkol.: V. A. Smolіj (golova) ta іn. ; Іnstitut іstorії Ukraїni NAN Ukraїni. K. : Naukova dumka, 2010. T. 7 : Ml O. S. 327. 728 s. [Ukrainian].
Velichko MV. Principi bіologіchnoї bezpeki ta bіologіchnogo zahistu yak zasadi fundamental'noї osnovi derzhavnoї sistemi protidії bіologіchnim zagrozam nacіonal'nіj bezpecі Ukraїni. YUridichna Ukraїna № 2/2021http://yu.yurincom.com/prynczypy-biologichnoyi-bezpeky-ta-biologichnogo-zahystu-yak-zasady-fundamentalnoyi-osnovy-derzhavnoyi-systemy-protydiyi-biologichnym-zagrozam-naczionalnij-bezpeczi-ukrayiny/[Ukrainian].
Naukova ta іnnovacіjna dіyal'nіst' unіversitetu v 2016 rocі: [іnform. ta analіt. materіali do zasіdannya Vchenoї radi un-tu 13 lyut. 2017 r.]; Nac. tekhn. un-t Ukraїni «Kiїv. polіtekhn. іn-t іm. Іgorya Sіkors'kogo» ; [uporyad.: M. YU. Іl'chenko ta іn ; za red. M. YU. Іl'chenka]. Kiїv: KPІ іm. І. Sіkors'kogo: Polіtekhnіka, 2017. 323 s. : іl., tabl. Nazva obkl. : Nauka KPІ іm. Іgorya Sіkors'kogo. 2016. [Ukrainian].
Zakon Ukraїni "Pro іnnovacіjnu dіyal'nіst'" (Vіdomostі Verhovnoї Radi Ukraїni (VVR), 2002, № 36, st.266, redakcіya vіd 12.04.2022). Dostupnij za posilannyam:https://zakon.rada.gov.ua/go/40-15. [Ukrainian].
Sacks LV, Shamsuddin HH, Yasinskaya YI, Bouri K, Lanthier ML, Sherman RE. Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012. JAMA. 2014 Jan 22-29;311(4):378-84. DOI: 10.1001/jama.2013.282542.
Busquet F, Hartung T. Corrigendum to "The need for strategic development of safety sciences". ALTEX. 2017;34(2):361. DOI: 10.14573/altex.1703281
